SUPERNUS PHARMAC.DL -,001 earnings per share and revenue

S49 earnings per share for the last quarter are 0.00 EUR whereas the estimation was 0.24 EUR which accounts for -100.00% surprise. Company revenue for the same period amounts to 133.13 M EUR despite the estimated figure of 135.15 M EUR. Estimated earnings per share for the next quarter are 0.36 EUR, and revenue is expected to reach 136.97 M EUR. Also watch annual changes over time to get a bigger picture of S49 earnings per share and revenue dynamics.